Published in Drug Week, March 10th, 2006
According to researchers in Brazil, "We tested the hypothesis that estrogen replacement (2 mg estradiol/day, orally for 90 days) would improve cardiopulmonary and functional capacities in postmenopausal women."
J.M. Aldrighi and colleagues a the University of Sao Paulo wrote, "Twenty-three postmenopausal and sedentary women were divided into estrogen replacement (n=13, 57 ±2 years) and placebo control (n=10, 58 ±2 years) groups. They performed a cardiopulmonary exercise test before and after the intervention. Baseline measurements were similar...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.